(Q40783768)

23 September 2017

Emotional responding in deficit and non-deficit schizophrenia (English)

1 reference

23 September 2017

0 references

Earnst KS

1

1 reference

PubMed ID

10622340

23 September 2017

Kring AM

series ordinal

2

1 reference

PubMed ID

10622340

23 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

23 September 2017

1 reference

23 September 2017

88

1 reference

23 September 2017

191-207

1 reference

23 September 2017

3

1 reference

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Affective and social-behavioral correlates of physical and social anhedonia in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Affect recognition in deficit syndrome schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Clinical correlates of the deficit syndrome of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Attentional impairments in deficit and nondeficit forms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Psychopathology and common sense.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Treatment of negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Deficit and nondeficit forms of schizophrenia: the concept

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Coefficient alpha and the internal structure of tests

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

A Controlled Trial of Amantadine in Drug-Induced Extrapyramidal Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Does affective blunting in schizophrenia reflect affective deficit or neuromotor dysfunction?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Construct validity of negative symptoms: an empirical and conceptual review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Emotion elicitation using films

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Anhedonia and the deficit syndrome of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Case identification and stability of the deficit syndrome of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Depressive symptoms and the deficit syndrome of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Facial expression of schizophrenic patients and their interaction partners.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Anhedonia, depression and the deficit syndrome of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Drug treatment of schizophrenia. Overview of recent research

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

The deficit state in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Platelet monoamine oxidase activity and deficit syndrome schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Intraclass correlations: uses in assessing rater reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

"Negative symptoms": conceptual and methodological problems

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Importance of akinesia: plasma chlorpromazine and prolactin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Emotional experience and expression in schizophrenia and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Do schizophrenic patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

Flat affect in schizophrenia does not reflect diminished subjective experience of emotion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900083-9

7 January 2021

10.1016/S0165-1781(99)00083-9

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

10622340